Circulating Tumor Cell and Metabolites as Novel Biomarkers for Early-Stage Lung Cancer Diagnosis

BACKGROUND: Lung cancer is a malignant tumor that has the highest morbidity and mortality rate among all cancers. Early diagnosis of lung cancer is a key factor in reducing mortality and improving prognosis. METHODS: In this study, we performed CTC next-generation sequencing (NGS) in early-stage lun...

Descripción completa

Detalles Bibliográficos
Autores principales: Wan, Lingling, Liu, Qingyi, Liang, Di, Guo, Yongdong, Liu, Guangjie, Ren, Jinxia, He, Yutong, Shan, Baoen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202280/
https://www.ncbi.nlm.nih.gov/pubmed/34136379
http://dx.doi.org/10.3389/fonc.2021.630672

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8202280/
https://www.ncbi.nlm.nih.gov/pubmed/34136379
http://dx.doi.org/10.3389/fonc.2021.630672

Ejemplares similares